Insulin resistance early metabolic defect Turner syndrome insulin resistance contributes risk diabetes patients Turner syndrome insulin sensitivity euglycemic insulin clamp technique whole body glucose lipid oxidation indirect calorimetry groups nondiabetic patients Turner syndrome age-matched normal controls Group young patients mean age yr hormone therapy group patients mean age yr estrogen therapy group glucose euglycemic clamp hepatic sensitivity euglycemic clamp insulin-stimulated glucose metabolism groups patients group controls group controls impairment insulin-stimulated glucose metabolism patients Turner syndrome reduced nonoxidative glucose disposal glucose oxidation similar extent Turner patients normal controls Insulin-induced suppression hepatic glucose production group plasma FFA chain amino acid levels Turner patients indistinguishable normal controls data patients Turner syndrome insulin resistance early metabolic nonoxidative pathways intracellular glucose metabolism 